• Ibotenic acid: NMDA Receptor Agonist for Neurodegeneration M

  2026-04-28

  Ibotenic acid is a validated NMDA receptor agonist widely used in neuroscience to induce targeted neuronal lesions and model neurodegenerative disorders. Its defined solubility, purity, and mechanistic specificity enable reproducible modulation of glutamatergic signaling. APExBIO provides high-purity ibotenic acid (B6246) for rigorous preclinical research applications.

• Praeruptorin A: Angular Pyranocoumarin for Translational Res

  2026-04-28

  Praeruptorin A offers a unique multi-pathway mechanism—combining anti-inflammatory, ferroptosis-inhibiting, and barrier-protective effects—for preclinical models of ulcerative colitis, metastasis, and cardiomyopathy. This guide details experimental workflows, protocol parameters, and troubleshooting strategies to maximize its utility as a next-generation angular pyranocoumarin compound.

• Catalpol Inhibits Liver Fibrosis via EphA2/FAK/Src-Glycolysi

  2026-04-27

  This study demonstrates that catalpol ameliorates hepatic fibrosis by directly targeting the EphA2/FAK/Src signaling axis, thereby inhibiting aerobic glycolysis in hepatic stellate cells. These findings offer mechanistic insight into antifibrotic strategies and highlight glycolytic pathway modulation as a promising therapeutic avenue.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guide

  2026-04-27

  FITC-Concanavalin A (ConA) Conjugate provides a specific, fluorescence-based approach for detecting α-D-glucose and α-D-mannose residues on cell surfaces in applications such as immunofluorescence, flow cytometry, and glycobiology research. It should only be used in carbohydrate-binding workflows and within its defined stability period. Non-carbohydrate applications or use beyond recommended storage conditions are not supported.

• BMS 309403: Advancing Atherosclerosis and Metabolic Disease

  2026-04-26

  Explore how the potent FABP4 inhibitor BMS 309403 transforms research into atherosclerosis and metabolic diseases. This article provides unique, protocol-driven insight into assay optimization and mechanistic understanding, setting it apart from prior content.

• ATM Inhibition Induces Macropinocytosis and Metabolic Adapta

  2026-04-25

  This study uncovers how inhibition of ATM kinase leads to enhanced macropinocytosis, enabling cancer cells to survive under nutrient-poor conditions. The findings identify a metabolic vulnerability in ATM-inhibited tumors that could inform future combinatorial cancer therapies.

• Trifluoperazine 2HCl: Precision Dopamine D2 Inhibition in Ad

  2026-04-24

  Explore how Trifluoperazine 2HCl empowers researchers to achieve precise dopamine D2 receptor inhibition in complex neuropharmacology and cancer models. Discover unique solvent strategies, mechanistic depth, and assay guidance not covered by existing resources.

• FITC-Concanavalin A (ConA) Conjugate: Lab Protocol and Guida

  2026-04-24

  The FITC-Concanavalin A (ConA) Conjugate provides a practical solution for detecting and visualizing α-D-glucose and α-D-mannose residues on cell surfaces in glycobiology workflows. It is ideal for immunofluorescence staining and flow cytometry carbohydrate detection, but should not be used for non-carbohydrate binding assays or beyond its stated stability period.

• MPTP Assay Kit: Advancing Quantitative Mitochondrial Dysfunc

  2026-04-23

  Explore the Mitochondrial Permeability Transition Pore Assay Kit for precise, quantitative mitochondrial permeability studies. This article reveals unique mechanistic insights, evidence-based protocols, and novel applications to cell death research.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Techn

  2026-04-23

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) safeguards protein samples from endogenous protease degradation during extraction and analysis, particularly when divalent cation preservation is required. It is not suitable for workflows where EDTA-based inhibition is essential or where DMSO could interfere with downstream assays.

• Substance P (B6620): Protocol Guidance for CNS Research

  2026-04-22

  Substance P (SKU B6620) is a high-purity tachykinin neuropeptide optimized for research on pain transmission, immune response modulation, and neuroinflammation. Its water solubility and neurokinin-1 receptor specificity enable reproducible protocols in CNS signaling studies. It is not suitable for applications requiring DMSO/ethanol solubility or long-term peptide storage.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-04-22

  Anlotinib hydrochloride stands out as a potent multi-target tyrosine kinase inhibitor for advanced anti-angiogenic assays, surpassing conventional agents in both selectivity and efficacy. This guide translates primary research and preclinical insights into actionable workflows, troubleshooting, and innovative strategy for tumor angiogenesis studies.

• Otilonium Bromide: Applied Antimuscarinic Agent in Cholinerg

  2026-04-21

  Otilonium Bromide from APExBIO enables precise, reproducible modulation of muscarinic receptors in neuroscience and smooth muscle studies. Its high purity, exceptional solubility, and robust receptor inhibition streamline experimental workflows and support next-generation cholinergic signaling research.

• Pexidartinib (PLX3397): Deep Dive into CSF1R Inhibition and

  2026-04-21

  Explore how Pexidartinib (PLX3397) enables nuanced manipulation of macrophage phenotypes through CSF1R-mediated signaling inhibition. This article reveals advanced insights and practical strategies for cancer research beyond standard workflow guides.

• Aurora A Kinase Controls Trained Immunity via SAM Metabolism

  2026-04-20

  Li et al. (2025) identify Aurora kinase A (AurA) as a central regulator of trained immunity by maintaining S-adenosylmethionine (SAM) metabolism in innate immune cells. Their findings reveal that AurA inhibition impairs chromatin accessibility and dampens the immune training response, with broad implications for cancer and immunology research.

15174 records 1/1012 page Next 12345 下5页 Last page